• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗的 SARS-CoV-2 疫情爆发:疫情的动态和两个独立传入的证据。

SARS-CoV-2 outbreak in Iran: The dynamics of the epidemic and evidence on two independent introductions.

机构信息

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Kariminejad-Najmabadi Pathology & Genetics Center, Tehran, Iran.

出版信息

Transbound Emerg Dis. 2022 May;69(3):1375-1386. doi: 10.1111/tbed.14104. Epub 2021 May 22.

DOI:10.1111/tbed.14104
PMID:33835709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8251331/
Abstract

The SARS-CoV-2 virus has been rapidly spreading globally since December 2019, triggering a pandemic, soon after its emergence. While Iran was among the first countries confronted with rapid spread of virus in February 2020, no real-time SARS-CoV-2 whole-genome tracking in early phase of outbreak was performed in the country. To address this issue, we provided 50 whole-genome sequences of viral isolates ascertained from different geographical locations in Iran during March-July 2020. The corresponding analysis on origins, transmission dynamics and genetic diversity of SARS-CoV-2 virus, represented at least two introductions of the virus into the country, constructing two major clusters defined as B.4 and B.1*. The first entry of the virus might have occurred around very late 2019/early 2020, as suggested by the time to the most recent common ancestor, followed by a rapid community transmission that led to dominancy of B.4 lineage in early epidemic till the end of June. Gradually, reduction in dominancy of B.4 occurred possibly as a result of other entries of the virus, followed by surge of B.1* lineages, as of mid-May. Remarkably, variation tracking of the virus indicated the increase in frequency of D614G mutation, along with B.1* lineages, which showed continuity till October 2020. The increase in frequency of D614G mutation and B.1* lineages from mid-May onwards predicts a rapid viral transmission that may push the country into a critical health situation followed by a considerable change in composition of viral lineages circulating in the country.

摘要

自 2019 年 12 月以来,SARS-CoV-2 病毒在全球迅速传播,引发了大流行。虽然伊朗是 2020 年 2 月第一批面临病毒快速传播的国家之一,但在疫情早期,该国并未对 SARS-CoV-2 进行实时全基因组追踪。为了解决这个问题,我们提供了 50 株病毒分离株的全基因组序列,这些病毒分离株是在 2020 年 3 月至 7 月期间从伊朗不同地理位置确定的。对 SARS-CoV-2 病毒的起源、传播动态和遗传多样性的相应分析表明,该病毒至少有两次传入该国,构成了两个主要的聚类,分别定义为 B.4 和 B.1*。病毒的第一次传入可能发生在 2019 年底/2020 年初,这是由最近共同祖先的时间所提示的,随后是快速的社区传播,导致 B.4 谱系在早期流行中占主导地位,直到 6 月底。随着其他病毒的传入,B.4 的主导地位逐渐下降,随后 B.1谱系在 5 月中旬激增。值得注意的是,病毒的变异跟踪表明,D614G 突变的频率增加,伴随着 B.1谱系的出现,这种情况一直持续到 2020 年 10 月。5 月中旬以来,D614G 突变和 B.1*谱系频率的增加预示着病毒的快速传播,这可能使该国陷入严重的健康状况,随后该国流行的病毒谱系组成将发生相当大的变化。

相似文献

1
SARS-CoV-2 outbreak in Iran: The dynamics of the epidemic and evidence on two independent introductions.伊朗的 SARS-CoV-2 疫情爆发:疫情的动态和两个独立传入的证据。
Transbound Emerg Dis. 2022 May;69(3):1375-1386. doi: 10.1111/tbed.14104. Epub 2021 May 22.
2
Disease Waves of SARS-CoV-2 in Iran Closely Mirror Global Pandemic Trends.伊朗的 SARS-CoV-2 疾病波与全球大流行趋势密切吻合。
Arch Iran Med. 2022 Aug 1;25(8):508-522. doi: 10.34172/aim.2022.83.
3
A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.西班牙的 SARS-CoV-2 早期传播归因于创始效应。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01583-20.
4
Phylogenetic and amino acid signature analysis of the SARS-CoV-2s lineages circulating in Tunisia.突尼斯流行的 SARS-CoV-2 谱系的系统发育和氨基酸特征分析。
Infect Genet Evol. 2022 Aug;102:105300. doi: 10.1016/j.meegid.2022.105300. Epub 2022 May 10.
5
Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.对 SARS-CoV-2 谱系的基因组监测表明,在巴西南部早期传播了令人关注的 P.1(Gamma)变体。
Microbiol Spectr. 2022 Feb 23;10(1):e0151121. doi: 10.1128/spectrum.01511-21. Epub 2022 Feb 16.
6
A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic.2020 年 4 月至 2021 年 1 月塞浦路斯 SARS-CoV-2 感染的综合分子流行病学分析:高度多源和不断进化的流行证据。
Viruses. 2021 Jun 9;13(6):1098. doi: 10.3390/v13061098.
7
Emergence of B.1.524(G) SARS-CoV-2 in Malaysia during the third COVID-19 epidemic wave.马来西亚在第三波 COVID-19 疫情期间出现的 B.1.524(G) 新型冠状病毒。
Sci Rep. 2021 Nov 11;11(1):22105. doi: 10.1038/s41598-021-01223-4.
8
Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa.南非开普敦多次引入 SARS-CoV-2。
Viruses. 2021 Mar 22;13(3):526. doi: 10.3390/v13030526.
9
Genomics, social media and mobile phone data enable mapping of SARS-CoV-2 lineages to inform health policy in Bangladesh.基因组学、社交媒体和移动电话数据可用于绘制 SARS-CoV-2 谱系图,为孟加拉国的卫生政策提供信息。
Nat Microbiol. 2021 Oct;6(10):1271-1278. doi: 10.1038/s41564-021-00955-3. Epub 2021 Sep 8.
10
SARS-CoV-2 genetic diversity in Venezuela: Predominance of D614G variants and analysis of one outbreak.委内瑞拉的 SARS-CoV-2 遗传多样性:D614G 变体占主导地位及一次暴发的分析。
PLoS One. 2021 Feb 19;16(2):e0247196. doi: 10.1371/journal.pone.0247196. eCollection 2021.

引用本文的文献

1
Effectiveness of dolutegravir in moderate severity COVID-19 patients: A single-center, randomized, double-blind, placebo-controlled trial.多替拉韦对中度新冠肺炎患者的疗效:一项单中心、随机、双盲、安慰剂对照试验。
Bioimpacts. 2024 Jun 26;15:29952. doi: 10.34172/bi.29952. eCollection 2025.
2
Comparative Atlas of SARS-CoV-2 Substitution Mutations: A Focus on Iranian Strains Amidst Global Trends.SARS-CoV-2 取代突变的比较图谱:关注全球趋势中的伊朗株。
Viruses. 2024 Aug 20;16(8):1331. doi: 10.3390/v16081331.
3
Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves.巴博勒市 4 家医院转诊的 COVID-19 患者的特征、结局、住院时间和循环阈值:第四、五、六波的多中心回顾性观察研究。
BMC Infect Dis. 2024 Jan 6;24(1):55. doi: 10.1186/s12879-023-08939-w.
4
Demographics, clinical characteristics, and outcomes in hospitalized patients during six waves of COVID‑19 in Northern Iran: a large cohort study.伊朗北部六波 COVID-19 期间住院患者的人口统计学、临床特征和结局:一项大型队列研究。
Sci Rep. 2023 Dec 18;13(1):22527. doi: 10.1038/s41598-023-50139-8.
5
Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy.靶向宿主钙通道和病毒孔蛋白:一种有前景的治疗新冠病毒的策略。
Future Virol. 2023 Aug. doi: 10.2217/fvl-2022-0203. Epub 2023 Sep 11.
6
Comparative Analysis and Identification of Spike Mutations in Iranian COVID-19 Samples from the First Three Waves of Disease.伊朗新冠疫情前三波中新冠病毒刺突蛋白突变的比较分析与鉴定
Adv Biomed Res. 2023 Jun 28;12:153. doi: 10.4103/abr.abr_171_22. eCollection 2023.
7
Implementation of an In-House Platform for Rapid Screening of SARS-CoV-2 Genome Variations.建立一个内部 SARS-CoV-2 基因组变异快速筛选平台。
Arch Iran Med. 2023 Feb 1;26(2):69-75. doi: 10.34172/aim.2023.12.
8
Genomic Diversity and Evolution of SARS-CoV-2 Lineages in Pakistan.巴基斯坦 SARS-CoV-2 谱系的基因组多样性与进化。
Viruses. 2023 Jun 27;15(7):1450. doi: 10.3390/v15071450.
9
Socio-demographical Profile of 7285 SARS-Cov-2 Positive Early Cases; Comparison with National Four Epidemic Waves.7285例新冠病毒阳性早期病例的社会人口学特征;与全国四次疫情波次的比较
Med J Islam Repub Iran. 2022 Aug 9;36:131. doi: 10.47176/mjiri.36.131. eCollection 2022.
10
Susceptibility and Severity of COVID-19 Are Both Associated With Lower Overall Viral-Peptide Binding Repertoire of HLA Class I Molecules, Especially in Younger People.COVID-19 的易感性和严重程度均与 HLA Ⅰ类分子的整体病毒肽结合库较低有关,尤其是在年轻人中。
Front Immunol. 2022 Jul 7;13:891816. doi: 10.3389/fimmu.2022.891816. eCollection 2022.

本文引用的文献

1
No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2.没有证据表明 SARS-CoV-2 反复出现的突变会增加传染性。
Nat Commun. 2020 Nov 25;11(1):5986. doi: 10.1038/s41467-020-19818-2.
2
Spike mutation D614G alters SARS-CoV-2 fitness.刺突突变 D614G 改变了 SARS-CoV-2 的适应性。
Nature. 2021 Apr;592(7852):116-121. doi: 10.1038/s41586-020-2895-3. Epub 2020 Oct 26.
3
Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America.在南美的 SARS-CoV-2 中,刺突蛋白和核衣壳蛋白发生了突变。
Infect Genet Evol. 2020 Nov;85:104557. doi: 10.1016/j.meegid.2020.104557. Epub 2020 Sep 17.
4
Impact of Circulating SARS-CoV-2 Mutant G614 on the COVID-19 Pandemic.循环的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)突变体G614对2019冠状病毒病(COVID-19)大流行的影响
Iran J Kidney Dis. 2020 Sep;14(5):331-334.
5
Infectivity of SARS-CoV-2: there Is Something More than D614G?新型冠状病毒(SARS-CoV-2)的传染性:除了D614G突变还有其他因素吗?
J Neuroimmune Pharmacol. 2020 Dec;15(4):574-577. doi: 10.1007/s11481-020-09954-3. Epub 2020 Sep 15.
6
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.SARS-CoV-2 与 ACE2 受体结合的分子相互作用和抑制。
Nat Commun. 2020 Sep 11;11(1):4541. doi: 10.1038/s41467-020-18319-6.
7
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.一种 SARS-CoV-2 疫苗候选物可能与所有当前流行的变异株相匹配。
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23652-23662. doi: 10.1073/pnas.2008281117. Epub 2020 Aug 31.
8
Geographic and Genomic Distribution of SARS-CoV-2 Mutations.新型冠状病毒2变异株的地理和基因组分布
Front Microbiol. 2020 Jul 22;11:1800. doi: 10.3389/fmicb.2020.01800. eCollection 2020.
9
Variant analysis of SARS-CoV-2 genomes.SARS-CoV-2 基因组变异分析。
Bull World Health Organ. 2020 Jul 1;98(7):495-504. doi: 10.2471/BLT.20.253591. Epub 2020 Jun 2.
10
Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.解析突变:D614G 对新冠疫情意味着什么仍不清楚。
Cell. 2020 Aug 20;182(4):794-795. doi: 10.1016/j.cell.2020.06.040. Epub 2020 Jul 3.